PLP1 and frontotemporal dementia: PLP1 expression, which was lower in FTD-MAPT specifically according to our mass spectrometry data, indeed shows a strong trend (p = 0.0595) for decreased expression in FTD-MAPT (see Additional File 11 for all immunoblotting results).